Elevated levels of IL-1, IL-6, and TNF-α in LPP may impair TG clearance by inhibiting lipoprotein lipase activity and reducing apoprotein-E levels, thus contributing to dyslipidemia [25]. The gene discussed is IL6; the disease is metabolic syndrome.